Cargando…
The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells
Lung cancer is the most common cause of cancer death in the United States. The genome of non-small cell lung cancer (NSCLC), the most frequent lung cancer type, is strongly affected by Long Interspersed Nuclear Element (LINE1) insertions. Active LINE1s are repetitive DNA sequences that can amplify t...
Autores principales: | Ramos, Kenneth S., Moore, Sara, Runge, Isabel, Tavera-Garcia, Marco A., Cascone, Ilaria, Courty, Jose, Reyes-Reyes, Elsa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959038/ https://www.ncbi.nlm.nih.gov/pubmed/31942196 http://dx.doi.org/10.7150/jca.37776 |
Ejemplares similares
-
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation
por: Chalabi-Dchar, Mounira, et al.
Publicado: (2021) -
Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin
por: Destouches, Damien, et al.
Publicado: (2008) -
LINE-1 couples EMT programming with acquisition of oncogenic phenotypes in human bronchial epithelial cells
por: Reyes-Reyes, Elsa M., et al.
Publicado: (2017) -
Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L
por: Birmpas, Charalampos, et al.
Publicado: (2012) -
Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma
por: Raineri, Fabio, et al.
Publicado: (2021)